Triple-threat treatment aims to make inoperable lung cancer removable
Disease control
Recruiting now
This Phase II trial tests whether giving a short course of radiation, followed by two cycles of immunotherapy (sintilimab) plus chemotherapy, can shrink advanced lung cancer that has spread to lymph nodes on the opposite side of the chest. The goal is to make the cancer operable …
Phase: PHASE2 • Sponsor: Yang Hong • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC